{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T08:26:46Z","timestamp":1788251206959,"version":"build-2803163510"},"reference-count":49,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"D-cure"},{"DOI":"10.13039\/501100004191","name":"Novo Nordisk","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004191","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Israeli HIV Association"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,8,16]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Diabetes mellitus (DM) is more common among people living with human immunodeficiency virus (PLWH) compared with healthy individuals. In a prospective multicenter study (N = 248), we identified normoglycemic (48.7%), prediabetic (44.4%), and diabetic (6.9%) PLWH. Glycosylated hemoglobin (HbA1c) and fasting blood glucose (FBG) sensitivity in defining dysglycemia was 96.8%, while addition of oral glucose tolerance test led to reclassification of only 4 patients. Inclusion of 93 additional PLWH with known DM enabled identification of multiple independent predictors of dysglycemia or diabetes: older age, higher body mass index, Ethiopian origin, HIV duration, lower integrase inhibitor exposure, and advanced disease at diagnosis. Shotgun metagenomic microbiome analysis revealed 4 species that were significantly expanded with hyperglycemia\/hyperinsulinemia, and 2 species that were differentially more prevalent in prediabetic\/diabetic PLWH. Collectively, we uncover multiple potential host and microbiome predictors of altered glycemic status in PLWH, while demonstrating that FBG and HbA1c likely suffice for diabetes screening. These potential diabetic predictors merit future prospective validation.<\/jats:p>","DOI":"10.1093\/infdis\/jiae167","type":"journal-article","created":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T16:08:36Z","timestamp":1711987716000},"page":"411-420","source":"Crossref","is-referenced-by-count":3,"title":["Diagnosis and Risk Factors of Prediabetes and Diabetes in People Living With Human Immunodeficiency Virus: Evaluation of Clinical and Microbiome Parameters"],"prefix":"10.1093","volume":"230","author":[{"given":"Omer","family":"Bar Ziv","sequence":"first","affiliation":[{"name":"Department of Military Medicine and \u201cZameret,\u201d Faculty of Medicine, Hebrew University, and Israel and Medical Corps, Israel Defense Forces"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7830-9994","authenticated-orcid":false,"given":"Avivit","family":"Cahn","sequence":"additional","affiliation":[{"name":"Diabetes Unit, Department of Endocrinology and Metabolism, Hadassah Medical Center"},{"name":"Faculty of Medicine, Hebrew University , Jerusalem"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tallulah","family":"Jansen","sequence":"additional","affiliation":[{"name":"Department of Systems Immunology, Weizmann Institute of Science , Rehovot"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valery","family":"Istomin","sequence":"additional","affiliation":[{"name":"HIV Service, Hillel-Yafe Medical Center , Hadera"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eynat","family":"Kedem","sequence":"additional","affiliation":[{"name":"Allergy, Immunology and AIDS Unit, Rambam Medical Center , Haifa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Olshtain-Pops","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Hebrew University , Jerusalem"},{"name":"Hadassah AIDS Center, Department of Clinical Microbiology and Infectious Diseases, Hadassah Medical Center , Jerusalem"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Israel","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Hebrew University , Jerusalem"},{"name":"Hadassah AIDS Center, Department of Clinical Microbiology and Infectious Diseases, Hadassah Medical Center , Jerusalem"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonatan","family":"Oster","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Hebrew University , Jerusalem"},{"name":"Hadassah AIDS Center, Department of Clinical Microbiology and Infectious Diseases, Hadassah Medical Center , Jerusalem"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Efrat","family":"Orenbuch-Harroch","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Hebrew University , Jerusalem"},{"name":"Hadassah AIDS Center, Department of Clinical Microbiology and Infectious Diseases, Hadassah Medical Center , Jerusalem"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maya","family":"Korem","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Hebrew University , Jerusalem"},{"name":"Hadassah AIDS Center, Department of Clinical Microbiology and Infectious Diseases, Hadassah Medical Center , Jerusalem"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"Strahilevitz","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Hebrew University , Jerusalem"},{"name":"Hadassah AIDS Center, Department of Clinical Microbiology and Infectious Diseases, Hadassah Medical Center , Jerusalem"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Itzchak","family":"Levy","sequence":"additional","affiliation":[{"name":"Infectious Diseases Unit, Sheba Medical Center , Tel Hashomer , Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Vald\u00e9s-Mas","sequence":"additional","affiliation":[{"name":"Department of Systems Immunology, Weizmann Institute of Science , Rehovot"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Ivanova","sequence":"additional","affiliation":[{"name":"Department of Systems Immunology, Weizmann Institute of Science , Rehovot"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5775-2110","authenticated-orcid":false,"given":"Eran","family":"Elinav","sequence":"additional","affiliation":[{"name":"Department of Systems Immunology, Weizmann Institute of Science , Rehovot"},{"name":"Division of Microbiome and Cancer, German Cancer Research Center , Heidelberg , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Shahar","sequence":"additional","affiliation":[{"name":"Allergy, Immunology and AIDS Unit, Rambam Medical Center , Haifa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9046-8130","authenticated-orcid":false,"given":"Hila","family":"Elinav","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Hebrew University , Jerusalem"},{"name":"Hadassah AIDS Center, Department of Clinical Microbiology and Infectious Diseases, Hadassah Medical Center , Jerusalem"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,4,1]]},"reference":[{"key":"2024081523531516400_jiae167-B1","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1001\/archinte.165.10.1179","article-title":"Antiretroviral therapy and the prevalence and incidence of diabetes mellitus in the Multicenter AIDS Cohort Study","volume":"165","author":"Brown","year":"2005","journal-title":"Arch Intern Med"},{"key":"2024081523531516400_jiae167-B2","author":"US Department of Health and Human Services Office of Minority Health"},{"key":"2024081523531516400_jiae167-B3","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1001\/jama.2017.19546","article-title":"Association of modifiable risk factors in young adulthood with racial disparity in incident type 2 diabetes during middle adulthood","volume":"318","author":"Bancks","year":"2017","journal-title":"JAMA"},{"key":"2024081523531516400_jiae167-B4","author":"US Department of Health and Human Services Office of Minority Health"},{"key":"2024081523531516400_jiae167-B5","doi-asserted-by":"crossref","first-page":"e0157354","DOI":"10.1371\/journal.pone.0157354","article-title":"Diabetes among Ethiopian immigrants to Israel: exploring the effects of migration and ethnicity on diabetes risk","volume":"11","author":"Jaffe","year":"2016","journal-title":"PLoS One"},{"key":"2024081523531516400_jiae167-B6","author":"Department of Health and Human Services"},{"key":"2024081523531516400_jiae167-B7","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.2337\/dc07-2013","article-title":"Incidence and risk factors for new-onset diabetes in HIV-infected patients: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study","volume":"31","author":"De Wit","year":"2008","journal-title":"Diabetes Care"},{"key":"2024081523531516400_jiae167-B8","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1086\/317541","article-title":"Metabolic abnormalities and cardiovascular disease risk factors in adults with human immunodeficiency virus infection and lipodystrophy","volume":"32","author":"Hadigan","year":"2001","journal-title":"Clin Infect Dis"},{"issue":"Suppl 1","key":"2024081523531516400_jiae167-B9","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.2337\/dc23-S002","article-title":"Erratum. 2. Classification and diagnosis of diabetes: standards of care in diabetes\u20142023","volume":"46","author":"ElSayed","year":"2023","journal-title":"Diabetes Care"},{"key":"2024081523531516400_jiae167-B10","doi-asserted-by":"crossref","first-page":"14","DOI":"10.2337\/cd21-as01","article-title":"Standards of medical care in diabetes\u20142021 abridged for primary care providers","volume":"39","author":"American Diabetes Association","year":"2021","journal-title":"Clin Diabetes"},{"issue":"Pt 1","key":"2024081523531516400_jiae167-B11","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1177\/000456329803500107","article-title":"The reproducibility and usefulness of the oral glucose tolerance test in screening for diabetes and other cardiovascular risk factors","volume":"35","author":"Ko","year":"1998","journal-title":"Ann Clin Biochem"},{"key":"2024081523531516400_jiae167-B12","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1055\/s-0030-1267183","article-title":"Comparison of HbA1c and OGTT criteria to diagnose diabetes among Chinese","volume":"119","author":"Dong","year":"2011","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"2024081523531516400_jiae167-B13","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1515\/jpm-2014-0208","article-title":"Reproducibility of a 75G oral glucose tolerance test in pregnant women","volume":"43","author":"Bonongwe","year":"2015","journal-title":"J Perinat Med"},{"key":"2024081523531516400_jiae167-B14","doi-asserted-by":"crossref","first-page":"545","DOI":"10.4172\/2155-6113.1000545","article-title":"Oral glucose tolerance testing identifies HIV+ infected women with diabetes mellitus (DM) not captured by standard DM definition","volume":"7","author":"Seang","year":"2016","journal-title":"J AIDS Clin Res"},{"key":"2024081523531516400_jiae167-B15","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.1093\/jac\/dku295","article-title":"Inaccuracy of haemoglobin A1c among HIV-infected men: effects of CD4 cell count, antiretroviral therapies and haematological parameters","volume":"69","author":"Slama","year":"2014","journal-title":"J Antimicrob Chemother"},{"issue":"2\u20133","key":"2024081523531516400_jiae167-B16","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1080\/25787489.2020.1766864","article-title":"Correlation between plasma glucose and hemoglobin A1c in HIV-infected individuals receiving zidovudine and non-zidovudine containing antiretroviral therapy regimens","volume":"21","author":"Saetang","year":"2020","journal-title":"HIV Res Clin Pract"},{"key":"2024081523531516400_jiae167-B17","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.2337\/dc09-0177","article-title":"A1c underestimates glycemia in HIV infection","volume":"32","author":"Kim","year":"2009","journal-title":"Diabetes Care"},{"key":"2024081523531516400_jiae167-B18","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1177\/0956462418823406","article-title":"Validity of hemoglobin A1c for diagnosing diabetes among people with and without HIV in Uganda","volume":"30","author":"Muchira","year":"2019","journal-title":"Int J STD AIDS"},{"key":"2024081523531516400_jiae167-B19","doi-asserted-by":"crossref","first-page":"571","DOI":"10.3851\/IMP1557","article-title":"Glycated haemoglobin in diabetic women with and without HIV infection: data from the Women's Interagency HIV Study","volume":"15","author":"Glesby","year":"2010","journal-title":"Antivir Ther"},{"key":"2024081523531516400_jiae167-B20","doi-asserted-by":"crossref","first-page":"e93","DOI":"10.2337\/dc10-0646","article-title":"Reduced time points to calculate the composite index","volume":"33","author":"DeFronzo","year":"2010","journal-title":"Diabetes Care"},{"key":"2024081523531516400_jiae167-B21","doi-asserted-by":"crossref","first-page":"335","DOI":"10.2337\/dc08-1478","article-title":"Oral disposition index predicts the development of future diabetes above and beyond fasting and 2-h glucose levels","volume":"32","author":"Utzschneider","year":"2009","journal-title":"Diabetes Care"},{"key":"2024081523531516400_jiae167-B22","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1146\/annurev-publhealth-090419-102644","article-title":"Prediabetes and what it means: the epidemiological evidence","volume":"42","author":"Echouffo-Tcheugui","year":"2021","journal-title":"Annu Rev Public Health"},{"key":"2024081523531516400_jiae167-B23","doi-asserted-by":"crossref","first-page":"509","DOI":"10.2147\/VHRM.S42350","article-title":"Increased burden and severity of metabolic syndrome and arterial stiffness in treatment-naive HIV+ patients from Cameroon","volume":"9","author":"Ngatchou","year":"2013","journal-title":"Vasc Health Risk Manag"},{"key":"2024081523531516400_jiae167-B24","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s12981-020-00284-1","article-title":"Prediabetes among HIV-infected individuals receiving antiretroviral therapy: prevalence, diagnostic tests, and associated factors","volume":"17","author":"Phuphuakrat","year":"2020","journal-title":"AIDS Res Ther"},{"key":"2024081523531516400_jiae167-B25","doi-asserted-by":"crossref","first-page":"197","DOI":"10.2147\/DMSO.S80084","article-title":"Diabetes mellitus and risk factors in human immunodeficiency virus\u2013infected individuals at Jimma University Specialized Hospital, southwest Ethiopia","volume":"8","author":"Mohammed","year":"2015","journal-title":"Diabetes Metab Syndr Obes"},{"key":"2024081523531516400_jiae167-B26","doi-asserted-by":"crossref","first-page":"e0235542","DOI":"10.1371\/journal.pone.0235542","article-title":"Prevalence of non-communicable diseases among individuals with HIV infection by antiretroviral therapy status in Dar es Salaam, Tanzania","volume":"15","author":"Kato","year":"2020","journal-title":"PLoS One"},{"key":"2024081523531516400_jiae167-B27","doi-asserted-by":"crossref","first-page":"10","DOI":"10.4314\/eamj.v85i1.9600","article-title":"Prevalence of dyslipidemia and dysglycaemia in HIV infected patients","volume":"85","author":"Manuthu","year":"2008","journal-title":"East Afr Med J"},{"key":"2024081523531516400_jiae167-B28","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1186\/s12879-018-3221-7","article-title":"Diabetes mellitus in HIV-infected patients: fasting glucose, A1c, or oral glucose tolerance test\u2014which method to choose for the diagnosis?","volume":"18","author":"Coelho","year":"2018","journal-title":"BMC Infect Dis"},{"key":"2024081523531516400_jiae167-B29","author":"European AIDS Clinical Society"},{"key":"2024081523531516400_jiae167-B30","doi-asserted-by":"crossref","first-page":"100235","DOI":"10.1016\/j.metop.2023.100235","article-title":"New onset type 2 diabetes mellitus risks with integrase strand transfer inhibitor\u2013based regimens: a systematic review and meta-analysis","volume":"17","author":"Kajogoo","year":"2023","journal-title":"Metabol Open"},{"key":"2024081523531516400_jiae167-B31","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/QAD.0b013e32834e8776","article-title":"Ten-year diabetes incidence in 1046 HIV-infected patients started on a combination antiretroviral treatment","volume":"26","author":"Capeau","year":"2012","journal-title":"AIDS"},{"key":"2024081523531516400_jiae167-B32","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1056\/NEJMoa1904340","article-title":"Dolutegravir-based or low-dose efavirenz-based regimen for the treatment of HIV-1","volume":"381","author":"Group","year":"2019","journal-title":"N Engl J Med"},{"key":"2024081523531516400_jiae167-B33","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1093\/cid\/ciz999","article-title":"Weight gain following initiation of antiretroviral therapy: risk factors in randomized comparative clinical trials","volume":"71","author":"Sax","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2024081523531516400_jiae167-B34","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1093\/cid\/ciab444","article-title":"Weight change following antiretroviral therapy switch in people with viral suppression: pooled data from randomized clinical trials","volume":"73","author":"Erlandson","year":"2021","journal-title":"Clin Infect Dis"},{"key":"2024081523531516400_jiae167-B35","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/QAI.0000000000001525","article-title":"Brief report: weight gain in persons with HIV switched from efavirenz-based to integrase strand transfer inhibitor\u2013based regimens","volume":"76","author":"Norwood","year":"2017","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2024081523531516400_jiae167-B36","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1097\/QAD.0000000000003289","article-title":"Relationship between weight gain and insulin resistance in people living with HIV switching to integrase strand transfer inhibitor\u2013based regimens","volume":"36","author":"Milic","year":"2022","journal-title":"AIDS"},{"key":"2024081523531516400_jiae167-B37","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.cell.2015.11.001","article-title":"Personalized nutrition by prediction of glycemic responses","volume":"163","author":"Zeevi","year":"2015","journal-title":"Cell"},{"key":"2024081523531516400_jiae167-B38","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nature12198","article-title":"Gut metagenome in European women with normal, impaired and diabetic glucose control","volume":"498","author":"Karlsson","year":"2013","journal-title":"Nature"},{"key":"2024081523531516400_jiae167-B39","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2337\/dc14-0769","article-title":"Insights into the role of the microbiome in obesity and type 2 diabetes","volume":"38","author":"Hartstra","year":"2015","journal-title":"Diabetes Care"},{"key":"2024081523531516400_jiae167-B40","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s12916-022-02254-y","article-title":"Effects of personalized diets by prediction of glycemic responses on glycemic control and metabolic health in newly diagnosed T2DM: a randomized dietary intervention pilot trial","volume":"20","author":"Rein","year":"2022","journal-title":"BMC Med"},{"key":"2024081523531516400_jiae167-B41","doi-asserted-by":"crossref","first-page":"193ra191","DOI":"10.1126\/scitranslmed.3006438","article-title":"Dysbiosis of the gut microbiota is associated with HIV disease progression and tryptophan catabolism","volume":"5","author":"Vujkovic-Cvijin","year":"2013","journal-title":"Sci Transl Med"},{"key":"2024081523531516400_jiae167-B42","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1038\/mi.2013.116","article-title":"An altered intestinal mucosal microbiome in HIV-1 infection is associated with mucosal and systemic immune activation and endotoxemia","volume":"7","author":"Dillon","year":"2014","journal-title":"Mucosal Immunol"},{"key":"2024081523531516400_jiae167-B43","doi-asserted-by":"crossref","first-page":"3899","DOI":"10.1016\/j.cell.2021.05.023","article-title":"Translocated microbiome composition determines immunological outcome in treated HIV infection","volume":"184","author":"Nganou-Makamdop","year":"2021","journal-title":"Cell"},{"key":"2024081523531516400_jiae167-B44","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/s41385-018-0083-7","article-title":"Low nadir CD4+ T-cell counts predict gut dysbiosis in HIV-1 infection","volume":"12","author":"Guillen","year":"2019","journal-title":"Mucosal Immunol"},{"key":"2024081523531516400_jiae167-B45","doi-asserted-by":"crossref","first-page":"434","DOI":"10.3389\/fcimb.2020.00434","article-title":"Gut microbiome changes associated with HIV infection and sexual orientation","volume":"10","author":"Zhou","year":"2020","journal-title":"Front Cell Infect Microbiol"},{"key":"2024081523531516400_jiae167-B46","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ebiom.2016.01.032","article-title":"Gut microbiota linked to sexual preference and HIV infection","volume":"5","author":"Noguera-Julian","year":"2016","journal-title":"EBioMedicine"},{"key":"2024081523531516400_jiae167-B47","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1186\/s40168-018-0580-7","article-title":"An exploration of Prevotella-rich microbiomes in HIV and men who have sex with men","volume":"6","author":"Armstrong","year":"2018","journal-title":"Microbiome"},{"key":"2024081523531516400_jiae167-B48","doi-asserted-by":"crossref","first-page":"e1007611","DOI":"10.1371\/journal.ppat.1007611","article-title":"Gut microbiota from high-risk men who have sex with men drive immune activation in gnotobiotic mice and in vitro HIV infection","volume":"15","author":"Li","year":"2019","journal-title":"PLoS Pathog"},{"key":"2024081523531516400_jiae167-B49","doi-asserted-by":"crossref","first-page":"e1010212","DOI":"10.1371\/journal.pcbi.1010212","article-title":"Dimensionality reduction of longitudinal \u2019omics data using modern tensor factorizations","volume":"18","author":"Mor","year":"2022","journal-title":"PLoS Comput Biol"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jid\/advance-article-pdf\/doi\/10.1093\/infdis\/jiae167\/57393732\/jiae167.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jid\/article-pdf\/230\/2\/411\/58809265\/jiae167.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jid\/article-pdf\/230\/2\/411\/58809265\/jiae167.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,15]],"date-time":"2024-08-15T23:55:19Z","timestamp":1723766119000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article\/230\/2\/411\/7637769"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,1]]},"references-count":49,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,4,1]]},"published-print":{"date-parts":[[2024,8,16]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jiae167","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,8,15]]},"published":{"date-parts":[[2024,4,1]]}}}